Inhibiting the transient receptor potential A1 ion channel
US10221177B2 · kind B2 · utility
2Cited by
0References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 18, 2015 |
| Grant date | Mar 5, 2019 |
| Priority date | — |
| Expiry date | Sep 18, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to pharmaceutical compounds of the Formula (I), or a pharmaceutically acceptable salt or composition thereof, and methods of their use for the treatment of pain, respiratory conditions, as well as inhibiting the Transient Receptor Potential A1 ion channel (TRPA1).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.